EUROPEAN MEDICAL SOLUTIONS |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0198 EUR | 0.00% |
|
-13.16% | -15.74% |
| Apr. 21 | DMS Imaging SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | DMS Imaging SA Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 29.89 | 6.83 | 4.86 | 4.904 | 82.82 | 35.01 |
| Enterprise Value (EV) 1 | 23.54 | 8.407 | 7.664 | 7.64 | 93.38 | 49.58 |
| P/E ratio | -1.9 x | -0.41 x | -3.57 x | 1.26 x | -14.9 x | -47 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 52.7 x | 6.31 x | 13.5 x | 11,817 x | 2.24 x | 0.82 x |
| EV / Revenue | 41.5 x | 7.77 x | 21.4 x | 18,409 x | 2.52 x | 1.17 x |
| EV / EBITDA | -1.88 x | -0.54 x | -14.9 x | 1.96 x | -45.4 x | 840 x |
| EV / FCF | -2.93 x | -1.22 x | -7.32 x | -4.31 x | -142 x | -10.8 x |
| FCF Yield | -34.2% | -82.2% | -13.7% | -23.2% | -0.71% | -9.25% |
| Price to Book | 4.88 x | -1.64 x | -0.86 x | -2.84 x | 7.84 x | 3.57 x |
| Nbr of stocks (in thousands) | 18,397 | 21,893 | 21,893 | 21,893 | 1,489,607 | 1,489,607 |
| Reference price 2 | 1.625 | 0.3120 | 0.2220 | 0.2240 | 0.0556 | 0.0235 |
| Announcement Date | 5/13/19 | 5/7/20 | 4/30/21 | 4/30/22 | 4/28/23 | 4/21/24 |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.567 | 1.082 | 0.3589 | 0.000415 | 37.06 | 42.52 |
| EBITDA 1 | -12.51 | -15.66 | -0.5147 | 3.894 | -2.055 | 0.059 |
| EBIT 1 | -12.77 | -15.95 | -0.6317 | 3.881 | -2.311 | -0.135 |
| Operating Margin | -2,251.68% | -1,474.37% | -175.98% | 935,124.1% | -6.24% | -0.32% |
| Earnings before Tax (EBT) 1 | -14.32 | -15.66 | -1.362 | 3.896 | -5.584 | -0.71 |
| Net income 1 | -14.32 | -15.66 | -1.362 | 3.895 | -5.578 | -0.709 |
| Net margin | -2,525.75% | -1,447.11% | -379.45% | 938,554.22% | -15.05% | -1.67% |
| EPS 2 | -0.8567 | -0.7693 | -0.0622 | 0.1779 | -0.003744 | -0.000500 |
| Free Cash Flow 1 | -8.04 | -6.913 | -1.047 | -1.773 | -0.6585 | -4.584 |
| FCF margin | -1,418.06% | -639.01% | -291.77% | -427,113.73% | -1.78% | -10.78% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 5/13/19 | 5/7/20 | 4/30/21 | 4/30/22 | 4/28/23 | 4/21/24 |
1EUR in Million2EUR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | 1.58 | 2.8 | 2.74 | 10.6 | 14.6 |
| Net Cash position 1 | 6.35 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | -0.1007 x | -5.448 x | 0.7027 x | -5.136 x | 247 x |
| Free Cash Flow 1 | -8.04 | -6.91 | -1.05 | -1.77 | -0.66 | -4.58 |
| ROE (net income / shareholders' equity) | -374% | -1,366% | 27.8% | -106% | -51.9% | -6.94% |
| ROA (Net income/ Total Assets) | -101% | -109% | -6.61% | 58.1% | -3.79% | -0.2% |
| Assets 1 | 14.21 | 14.42 | 20.6 | 6.708 | 147.1 | 351.5 |
| Book Value Per Share 2 | 0.3300 | -0.1900 | -0.2600 | -0.0800 | 0.0100 | 0.0100 |
| Cash Flow per Share 2 | 0.4400 | 0.1700 | 0.1300 | 0.0600 | 0 | 0 |
| Capex 1 | 0.37 | 0.1 | - | - | 2.21 | 2.57 |
| Capex / Sales | 65.43% | 8.97% | - | - | 5.96% | 6.04% |
| Announcement Date | 5/13/19 | 5/7/20 | 4/30/21 | 4/30/22 | 4/28/23 | 4/21/24 |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -15.74% | 31.58M | |
| -18.02% | 8.42B | |
| +74.52% | 4.35B | |
| +7.88% | 2.74B | |
| -56.54% | 1.78B | |
| -15.14% | 1.7B | |
| -16.41% | 1.47B | |
| +15.43% | 1.19B | |
| -49.10% | 1.03B | |
| -21.78% | 927M |
- Stock Market
- Equities
- DMSIM Stock
- Financials European Medical Solutions
